Normal tension glaucoma: from the brain to the eye or the inverse?Hui-Jun Zhang, Xue-Song Mi, Kwok-Fai So1845-1850
Mesenchymal stromal cell therapy for damaged retinal ganglion cells, is gold all that glitters?Fernando Lucas-Ruiz, Caridad Galindo-Romero, David García-Bernal, María Norte-Mu?oz, Kristy T. Rodríguez-Ramírez, Manuel Salinas-Navarro, Jose E. Millán-Rivero, Manuel Vidal-Sanz, Marta Agudo-Barriuso1851-1857
MicroRNAs as biomarkers of diabetic retinopathy and disease progressionBridget Martinez, Philip V. Peplow1858-1869
Diabetic neuropathy research: from mouse models to targets for treatmentVuong M. Pham, Shinji Matsumura, Tayo Katano, Nobuo Funatsu, Seiji Ito1870-1879
Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’sdiseaseBhaskar C. Das, Somsankar Dasgupta, Swapan K. Ray1880-1892
Sigma-2 receptor as a potential therapeutic target for treating central nervous system disordersKazuki Terada, Keisuke Migita, Yukari Matsushima, Chiaki Kamei1893-1894
Therapeutic implications of advanced age at time of spinal cord injuryAndrew N. Stewart, John C. Gensel, Bei Zhang1895-1896
Inducing α-synuclein compaction: a new strategy for inhibiting α-synuclein aggregation?Francisca Pinheiro, Salvador Ventura1897-1898
Tubulin glutamylation: a skeleton key for neurodegenerative diseasesSiem van der Laan, Geronimo Dubra, Krzysztof Rogowski1899-1900
Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegenerationAntonella Amato, Flavia Mul1901-1902
